地中海贫血患者的治疗方案研究

Research Progress in the Treatment of Thalassemia Patients

地中海贫血作为一种遗传性血液疾病,由调节血红蛋白基因突变导致珠蛋白链形成障碍而引起,其遗传方式为常染色体隐性遗传,临床症状表现有铁过载、慢性溶血性贫血等。随着医疗技术的进步,地中海贫血的治疗手段也随之增多,如输血治疗、去铁治疗、药物治疗、基因治疗以及造血干细胞移植等,为深入认识各种治疗方法治疗地中海贫血的效果,为疾病治疗方案提供合理且有效的参考依据,本文采用文献分析法,详细论述地中海贫血患者的中西医治疗方案及研究进展。

Thalassemia,as a hereditary blood disease,is caused by disorders in the formation of globin chains caused by mutations in the hemoglobin gene.Its genetic pattern is autosomal recessive inheritance,and clinical symptoms include iron overload,chronic hemolytic anemia,etc.With the advancement of medical technology,the treatment methods for thalassemia have also increased,such as blood transfusion therapy,iron removal therapy,drug therapy,gene therapy,and hematopoietic stem cell transplantation.In order to gain a deeper understanding of the effectiveness of various treatment methods for thalassemia and provide a reasonable and effective reference for the clear treatment plan of the disease,this article provides a detailed discussion on the treatment research progress of thalassemia patients.